IVY HEALTH CARE

Pregnancy Screening Tests: What Each One Tells You

Pregnancy involves several rounds of screening — first-trimester combined screening or NIPT, the second-trimester anomaly scan, gestational diabetes testing, and sometimes genetic carrier screening. It’s worth understanding upfront that screening tests estimate risk; they don’t diagnose a condition on their own, which is the single most useful thing to know before getting any of these results back.

Diagnostic vs. screening tests — the difference that matters most

This distinction resolves more confusion than almost anything else in prenatal care, so it’s worth leading with it. A screening test estimates the likelihood of a condition being present — it carries no physical risk to the pregnancy, but it can’t give a definitive yes or no on its own. A diagnostic test, like amniocentesis or chorionic villus sampling (CVS), can give a definitive answer, but it involves a small procedural risk, including a small risk of miscarriage, which is exactly why it’s not used as a first-line test for everyone. The typical sequence is screening first, and diagnostic testing offered only if a screening result raises enough concern to make that additional risk worth considering — not the other way around.

First-trimester screening

Combined first-trimester screening pairs the NT ultrasound measurement with a blood test, giving a risk estimate for certain chromosomal conditions, typically available from around 11 to 14 weeks.

Second-trimester screening

The anomaly scan around 18–20 weeks is the main second-trimester screening tool, providing a detailed structural assessment of the baby's development — see our Obstetric Ultrasound Scan page for what this specifically involves.

Gestational diabetes screening

Typically done between 24 and 28 weeks using an oral glucose tolerance test, which checks how your body processes sugar during pregnancy — gestational diabetes is common, generally very manageable once identified, and screening for it routinely is part of why outcomes for both mother and baby have improved significantly over time.

Genetic carrier screening

A separate category from the screening above, genetic carrier screening checks whether you or your partner carry a gene for a specific inherited condition — relevant particularly where a condition like thalassemia, common in this part of India, runs in either family, or simply as a proactive check some couples choose regardless of family history.

Understanding a 'high risk' screening result

A screening result that comes back “high risk” is one of the more anxiety-inducing moments in prenatal care, and it’s worth repeating plainly: it is not a diagnosis. It means the estimated likelihood of a condition is higher than the general population average, which is exactly the point at which diagnostic testing — amniocentesis or CVS — is typically offered, if you choose to pursue a definitive answer. Many pregnancies flagged as higher risk on screening go on to have entirely normal diagnostic results, and that gap between a risk estimate and reality is precisely why the two types of test exist as separate steps rather than one combined answer.

Discuss your screening options

Book a consultation at our Gachibowli centre.

Frequently asked questions

NIPT is generally more accurate for the specific conditions it screens for, though it’s a newer test and typically costs more — worth discussing which fits your situation and priorities.

No — it means the estimated likelihood is elevated, not that a condition is confirmed. Diagnostic testing is the step that can give a definitive answer, and many high-risk screening results turn out normal on further testing.

Both carry a small procedural risk, including a small risk of miscarriage, which is why they’re offered selectively rather than to everyone — your doctor can walk you through the actual risk relevant to your situation if this is being considered.

Not everyone needs it, but many carriers of recessive conditions have no family history at all, since a single copy of the gene causes no symptoms — some couples choose it proactively for that reason, worth discussing at a preconception or early pregnancy visit.

You’ll be guided through a management plan — usually diet and monitoring first, medication if needed — rather than treated as an emergency. See our High-Risk Pregnancy page for more detail.